Skip to main content

Genetic Databases

‘Anonymous’ genetic databases vulnerable to privacy leaks


A study has raised concerns that a type of genetic database that is increasingly popular with researchers could be exploited to reveal the identities of its participants, or link private health information to their public genetic profiles.

Single-cell data sets can contain information on gene expression in millions of cells collected from thousands of people. They are often freely accessible, providing a valuable resource for researchers who study the effects of diseases at a cellular level. The data are supposed to be anonymized, but a study published on 2 October in Cell shows how genetic data from one study “can be exploited to uncover private information about individuals in another study”, the authors write.

The findings highlight the difficulty of balancing the interests of researchers with the privacy of donors. “Our genomes are very identifying. They can tell a lot about us, our traits, our predisposition to diseases,” says study co-author Gamze Gürsoy, a bioinformatics researcher at Columbia University in New York City. “You can change your credit-card number if it leaks, but you cannot change your genome.”
Sensitive data

Concerns around privacy in genetic data sets have been raised before, but they mainly focused on ‘bulk’ genetic data sets. These contain information on gene activity averaged across a large population of cells rather than data of an individual cell.

It was previously thought that single-cell data sets wouldn’t be as vulnerable to privacy leaks, owing to the level of ‘noise’, or variation in gene expression, between different cells. But Gürsoy and her colleagues demonstrated that was not the case.

The team reviewed three publicly available single-cell data sets, which included blood cells from people with lupus, a chronic autoimmune disease. The researchers found that they could use data on gene expression to predict the structure of a person’s genome, by combining these values with information on expression quantitative trait loci (eQTLs). The details of eQTLs — variations on the chromosome that correlate with gene expression — are also publicly available on single-cell data sets.

To test the reliability of their work, the researchers checked their genome predictions against a genome database corresponding with the cells they used. They were able to link most of the data sets to their corresponding genome, with an accuracy rate of more than 80%.

Unlike the data on gene expression and eQTLs, full-genome databases can usually be accessed only by scientists, to protect donor’s identifying information. But the researchers point out that a participant’s genome data can be publicly available elsewhere. For example, they might have uploaded it to a genealogy website in which users send DNA samples to learn more about their ancestry. In this case, an attacker could identify an individual whose cells are in a single-cell data set using their genome. This could reveal personal data related to a sensitive trait such as a psychiatric disorder, given that research participants are often selected to study the biology of these complex conditions.

Privacy breaches such as these could have real-world implications, including causing employment discrimination, says Gürsoy. She adds that any leaks could even have repercussions for future generations, given that genetic traits can be passed to offspring. “Anything that leaks about us will perpetuate through generations,” she says.

Bradley Malin, who researches large-scale genomic data sharing at Vanderbilt University in Nashville, Tennessee, says that the study is a “novel extension and contribution to the literature”. He adds that future research could explore whether genomic data could still be linked in larger data sets that include samples from thousands or millions of people.

Competing interests

Scientists are unsure about how best to tackle these privacy concerns. “There’s the desire to protect individual privacy, but also the desire to collectively advance medical research, and those are, unfortunately, at odds with each other,” says Mark Gerstein, who researches medical data science at Yale University in New Haven, Connecticut. The simplest solution would be to stop making genetic data so easily accessible, but this would negatively affect research, he says. “We need to share and aggregate large amounts of information.” he says. “Locking it down and making it more private, really, just gums that whole process up.”

In their study, Gürsoy and her colleagues say that there should be greater transparency about the risks for participants who share their genomic data, and suggest that researchers should ensure that donors give consent for their data being shared. Another way forward could be encrypting personal data when it is part of a public database. The authors acknowledge that doing this would complicate the process of building and maintaining data sets, but say that it could help to protect participants’ privacy.

#GeneticPrivacy, #DataLeaks, #AnonymousDatabases, #PrivacyConcerns, #GeneticInformation, #ReIdentification, #GenomicStudies, #DataSecurity, #PrivacyLeaks, #DataVulnerability, #SecurityRisks, #GeneticResearch, #ConsentMatters, #IdentityTracing, #GenomicPrivacy, #GeneticData, #PublicDataRisks, #DataProtection, #GeneticSecurity, #HealthData

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 

Comments

Post a Comment

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...
Post a Comment
Read more

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...
Post a Comment
Read more

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...
Post a Comment
Read more